NMRD OTC
Nemaura Medical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.00001-0.0005
Volume500
Avg Volume1,191
Beta0.92
Dividend—
Analyst Ratings
Company Info
CEODewan Fazlul Hoque Chowdhury
Employees38
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-02-05
Websitenemauramedical.com
57 West 57th Street
New York City, NY 10019
US
New York City, NY 10019
US
646 416 7912
About Nemaura Medical Inc.
Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invasive continuous glucose monitoring (CGM) system. This device is designed to assist individuals with Type 1 and Type 2 diabetes in managing their condition, and it can also screen for pre-diabetic states. Beyond this, Nemaura offers proBEAT, a wellness guidance service that delivers educational prompts to users about factors influencing their blood sugar profiles. The company also conducts specialized programs aimed at diabetes prevention and reversal. Established in 2009, Nemaura Medical Inc. operates from its headquarters in New York City.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Ghadar-Ghadr Arash | P-Purchase | 100,000 | $0.14 | 2024-01-05 |
| Mclarney Justin Jame | A-Award | 22,293 | — | 2022-01-31 |
| Natha Salim | A-Award | 8,000 | $3.98 | 2022-01-28 |
| Moore Thomas Peter | A-Award | 8,000 | $3.98 | 2022-01-28 |
| Johnson Timothy Chri | A-Award | 8,000 | $3.98 | 2022-01-28 |